The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preclinical testing of FOLR1-CAR T cells against osteosarcoma (OS).
 
Michelle Choe
No Relationships to Disclose
 
Danielle Kirkey
No Relationships to Disclose
 
Rhonda E Ries
No Relationships to Disclose
 
Tiffany Hylkema
Stock and Other Ownership Interests - Moderna Therapeutics; Quest Diagnostics
 
Sarah J Menashe
No Relationships to Disclose
 
Lara E. Davis
Consulting or Advisory Role - Daiichi Sankyo; Regeneron; SpringWorks Therapeutics
Research Funding - Bayer (Inst); BTG (Inst); Eisai (Inst); Novartis (Inst)
 
Michael J Wagner
Consulting or Advisory Role - AADi; Adaptimmune; Deciphera; Epizyme
Research Funding - Adaptimmune (Inst); Athenex (Inst); Deciphera (Inst); Foghorn Therapeutics (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Presage Biosciences (Inst)
Travel, Accommodations, Expenses - Epizyme
 
Lee D. Cranmer
Research Funding - AADi (Inst); Advenchen Laboratories (Inst); Astellas Pharma (Inst); CBA Research (Inst); Exelixis (Inst); Iterion Therapeutics (Inst); Lilly (Inst); Merck (Inst); Philogen (Inst); TRACON Pharma (Inst)
 
Sanjay Malhotra
No Relationships to Disclose
 
Richard Greg Gorlick
Research Funding - Eisai (Inst)
 
Soheil Meshinchi
No Relationships to Disclose
 
Elizabeth Trice Loggers
Research Funding - Ayala Pharmaceuticals (Inst); BioAtla (Inst); Epizyme (Inst); Karyopharm Therapeutics (Inst); SpringWorks Therapeutics (Inst)